Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription Articles published in Acta Neuropathol Retrieve available abstracts of 131 articles: HTML format

Single Articles

September 2026
1. MULVEY B, Divecha HR, Tippani M, Bach SV, et al
   Molecular programs in human locus coeruleus link APOE and neuromelanin to Alzheimer's vulnerability.
   Acta Neuropathol. 2026;152:32.
   PubMed     Abstract available
   
   
   
2. MASTRANGELO A, Baiardi S, Ruggeri E, Bentivenga GM, et al
   Changes in five cerebrospinal fluid and three plasma Alzheimer's disease biomarkers across increasing brain amyloid-beta and tau pathology burden.
   Acta Neuropathol. 2026;152:28.
   PubMed     Abstract available
   
   
   August 2026
3. RANA JK, Pinarbasi ES, Fernandez MG, Navratna V, et al
   Correction: CTE-type tau filaments in Alzheimer's disease with co-morbid LATE-NC.
   Acta Neuropathol. 2026;152:23.
   PubMed    
   
   
   
4. THIERRY M, Leitner D, Balcomb K, Kavanagh T, et al
   Proteomic comparison of hippocampal neurofibrillary tangles in PART, intermediate Alzheimer's disease and advanced Alzheimer's disease.
   Acta Neuropathol. 2026;152:13.
   PubMed     Abstract available
   
   
   July 2026
5. SANTIAGO J, Poceviciute D, Sallberg T, Onnerfjord P, et al
   Retinal proteome changes mirror brain pathology and reveal synaptic and cytoskeletal dysfunction in Alzheimer's disease.
   Acta Neuropathol. 2026;152:12.
   PubMed     Abstract available
   
   
   
6. RANA JK, Pinarbasi ES, Fernandez MG, Navratna V, et al
   CTE-type tau filaments in Alzheimer's disease with co-morbid LATE-NC.
   Acta Neuropathol. 2026;152:3.
   PubMed    
   
   
   June 2026
7. DI BARI MA, Bruno R, Riccardi G, Vanni I, et al
   Prion-like transmission and propagation of human beta-amyloid to the bank vole rodent model.
   Acta Neuropathol. 2026;151:75.
   PubMed     Abstract available
   
   
   
8. KAC PR, Cousins KAQ, Szadziewska A, Shaw LM, et al
   Tau368 improves p-tau diagnostic accuracy for FTLD-tau from FTLD-TDP.
   Acta Neuropathol. 2026;151:71.
   PubMed     Abstract available
   
   
   
9. WELIKOVITCH LA, Oakley DH, Bennett RE, Serrano-Pozo A, et al
   Neuropathological study of the effects of aducanumab anti-Abeta immunotherapy on patients with Alzheimer's disease.
   Acta Neuropathol. 2026;151:68.
   PubMed     Abstract available
   
   
   
10. FANCY NN, Willumsen N, Chau VMN, Boulger SL, et al
    Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.
    Acta Neuropathol. 2026;151:67.
    PubMed     Abstract available
    
    
    
11. SEIFFER S, Rotter J, Brendler J, Ricken A, et al
    Expression of GPR34 in microglia remains stable in human Alzheimer's disease.
    Acta Neuropathol. 2026;151:66.
    PubMed     Abstract available
    
    
    
12. DUNOT J, Gandin C, Truchi M, Pirro G, et al
    AETA peptide contributes to Alzheimer's disease signature of synapse dysfunction.
    Acta Neuropathol. 2026;151:65.
    PubMed     Abstract available
    
    
    May 2026
13. RICHARDSON TE, Cherry J, Kandoi S, Rohde SK, et al
    Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration.
    Acta Neuropathol. 2026;151:61.
    PubMed     Abstract available
    
    
    
14. SINGH A, Denkinger MN, Leuzy A, Dieckhoff K, et al
    A plasma protein signature for cerebral amyloid angiopathy.
    Acta Neuropathol. 2026;151:59.
    PubMed     Abstract available
    
    
    
15. FLORES-AGUILAR L, Zaikos TD, Rivera I, Wright ST, et al
    Frequency of mixed neuropathologies in individuals with down syndrome with and without Alzheimer's dementia.
    Acta Neuropathol. 2026;151:55.
    PubMed     Abstract available
    
    
    
16. ROBINSON JL, Cai H, Loh NJ, Vazquez O, et al
    Idiotypic-susceptible Alzheimer's disease: a clinically relevant, neurofibrillary tangle subtype.
    Acta Neuropathol. 2026;151:51.
    PubMed     Abstract available
    
    
    April 2026
17. YUAN S, Essepian N, Roberts R, Sherman E, et al
    Tau oligomerization induces nuclear lamina invagination and chromatin remodeling in Alzheimer's disease.
    Acta Neuropathol. 2026;151:43.
    PubMed     Abstract available
    
    
    
18. LIU QR, Zhu M, Perez K, Yao Q, et al
    Ser423-phosphorylated MECP2 (MECP2-pS423) accumulates in human brain, cerebrospinal fluid and serum in sporadic Alzheimer's disease.
    Acta Neuropathol. 2026;151:38.
    PubMed     Abstract available
    
    
    
19. MELIKYAN ZA, Al-Darsani Z, Jiang L, Colcord KA, et al
    Contribution of health history and neuropathologic changes to the likelihood of dementia in those with intermediate/high Alzheimer's pathology: findings from The 90 + Study.
    Acta Neuropathol. 2026;151:36.
    PubMed     Abstract available
    
    
    
20. HAQ I, Ngo JC, Roy N, Lee E, et al
    Alzheimer's disease risk protein SorLA regulates ER homeostasis and lipid metabolism in human microglia, with conserved effects in neurons.
    Acta Neuropathol. 2026;151:37.
    PubMed     Abstract available
    
    
    March 2026
21. THORNS V, Mallory M, Hansen L, Masliah E, et al
    Correction: Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant.
    Acta Neuropathol. 2026;151:33.
    PubMed    
    
    
    
22. PASCUAL JR, Rivera I, Nguyen H, Ngo PT, et al
    Neuropathological measures of increased tau phosphorylation across the Down syndrome lifespan.
    Acta Neuropathol. 2026;151:28.
    PubMed     Abstract available
    
    
    
23. SALEEM T, Mobius W, Schmitz M, da Silva Correia A, et al
    A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.
    Acta Neuropathol. 2026;151:27.
    PubMed     Abstract available
    
    
    February 2026
24. CHEN Y, La Joie R, Pereira FL, Blazhenets G, et al
    Disentangling on and off-target binding in flortaucipir PET: a voxel-to-voxel P-tau, ferric iron, and MAO-B histology-to-flortaucipir PET comparison.
    Acta Neuropathol. 2026;151:21.
    PubMed     Abstract available
    
    
    
25. LAROCHE VT, Cavill R, Kouhsar M, Muller J, et al
    Epigenomic subtypes of late-onset Alzheimer's disease reveal distinct microglial signatures.
    Acta Neuropathol. 2026;151:20.
    PubMed     Abstract available
    
    
    
26. ONO D, Kondrakunta S, Mak E, Przybelski SA, et al
    Neuropathologic basis of quantitative susceptibility mapping in the substantia nigra: contributions of tau, pigmented neurons, and iron.
    Acta Neuropathol. 2026;151:17.
    PubMed     Abstract available
    
    
    January 2026
27. FERTAN E, Kedia S, Nolan G, Meisl G, et al
    Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.
    Acta Neuropathol. 2026;151:7.
    PubMed     Abstract available
    
    
    December 2025
28. MOHANTY R, Wheatley S, Chiotis K, Marseglia A, et al
    Distinct cerebrovascular pathways underlying Alzheimer's disease-related neurodegeneration.
    Acta Neuropathol. 2025;150:64.
    PubMed     Abstract available
    
    
    
29. TAYLOR LW, Simzer EM, Young LFP, Holt K, et al
    Confirmation of p-tau Ser356's association with Alzheimer's disease pathology and lowering in response to WZ4003 treatment in brain slice cultures. Reply to: "Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology".
    Acta Neuropathol. 2025;150:63.
    PubMed    
    
    
    
30. LE LTHL, Lee G, Shin JW, Shim YM, et al
    Phospho-tau Ser356 is mostly confined to pre-NFT neurons in Alzheimer's pathology.
    Acta Neuropathol. 2025;150:62.
    PubMed    
    
    
    
31. LIANG H, Hunt JB Jr, Ma C, Kovalenko A, et al
    Probing tau citrullination in Alzheimer's disease brains and mouse models of tauopathy.
    Acta Neuropathol. 2025;150:61.
    PubMed     Abstract available
    
    
    November 2025
32. IOANNOU K, Perrin RJ, Abdullaieva K, Bluma M, et al
    Neuropathologic correlates of cognitive impairment in Alzheimer's disease with discordant CSF biomarker profiles: co-pathologies in focus.
    Acta Neuropathol. 2025;150:57.
    PubMed     Abstract available
    
    
    
33. PHUONG HT, Tomas RF, Akmese C, Mijares A, et al
    PolyGR-containing aggregates link with pathology and clinical features of Alzheimer's disease.
    Acta Neuropathol. 2025;150:49.
    PubMed     Abstract available
    
    
    October 2025
34. NEUBAUER A, Weissenbrunner D, Pekrun S, Roeber S, et al
    Alpha-synuclein deposition patterns in Alzheimer's disease: association with cortical amyloid beta and variable tau load.
    Acta Neuropathol. 2025;150:46.
    PubMed     Abstract available
    
    
    
35. ZHANG Z, Capuano AW, Beadell A, Tasaki S, et al
    Brain-derived 5-hydroxymethylcytosine epigenetic scores are related to Alzheimer's disease pathology and cognitive decline.
    Acta Neuropathol. 2025;150:45.
    PubMed     Abstract available
    
    
    
36. AUGUR ZM, Fogo GM, Arbery MR, Hsieh YC, et al
    Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.
    Acta Neuropathol. 2025;150:43.
    PubMed     Abstract available
    
    
    
37. INOUE Y, Wang H, Heckman MG, Ren Y, et al
    Impact of APOE on cerebrovascular lipid profile in Alzheimer's disease.
    Acta Neuropathol. 2025;150:39.
    PubMed     Abstract available
    
    
    September 2025
38. VAN WETERING J, Deshayes NAC, Boone J, Rodrigues Fernandes I, et al
    Limbic Alzheimer's co-pathology in multiple system atrophy is associated with cognitive impairment and diagnostic inaccuracy.
    Acta Neuropathol. 2025;150:30.
    PubMed     Abstract available
    
    
    
39. TOME SO, Gawor K, Ospitalieri S, Ronisz A, et al
    Differences and overlaps in TDP-43 pathology of 'pure' LATE-NC compared to LATE-NC coexisting with Alzheimer's disease.
    Acta Neuropathol. 2025;150:28.
    PubMed     Abstract available
    
    
    
40. OGG J, Postupna N, Gibbons LE, Ariza J, et al
    Down syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease.
    Acta Neuropathol. 2025;150:24.
    PubMed     Abstract available
    
    
    August 2025
41. NELSON PT, Crary JF
    PART and amyloid cascade hypotheses are alive and well (but are not so simple). Scientific commentary on: "Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits"
    Acta Neuropathol. 2025;150:14.
    PubMed    
    
    
    July 2025
42. MUKHERJEE S, Coyle R, Dubois C, Perez K, et al
    Isomerized Abeta in the brain can distinguish the status of amyloidosis in the Alzheimer's disease spectrum.
    Acta Neuropathol. 2025;150:7.
    PubMed     Abstract available
    
    
    
43. MARTINEZ-PEREZ DA, McGlothan JL, Rodichkin AN, Abilmouna K, et al
    Amyloid-beta plaque-associated microglia drive TSPO upregulation in Alzheimer's disease.
    Acta Neuropathol. 2025;150:6.
    PubMed     Abstract available
    
    
    June 2025
44. DOURTE M, Paitre E, Bouchoucha M, Boyer E, et al
    The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.
    Acta Neuropathol. 2025;149:64.
    PubMed     Abstract available
    
    
    
45. CHEN CD, Franklin EE, Li Y, Joseph-Mathurin N, et al
    Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.
    Acta Neuropathol. 2025;149:57.
    PubMed     Abstract available
    
    
    
46. ONDREJCAK T, Hu NW, Coode E, Campbell T, et al
    Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region.
    Acta Neuropathol. 2025;149:56.
    PubMed     Abstract available
    
    
    
47. LIAO F, Calvo-Rodriguez M, Chhaya M, Sefrin JP, et al
    Anti-pyroglutamate-3 Abeta immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Abeta amyloidosis.
    Acta Neuropathol. 2025;149:55.
    PubMed     Abstract available
    
    
    May 2025
48. SADLEIR KR, Gomez KP, Edwards AE, Patel AJ, et al
    Annexin A6 membrane repair protein protects against amyloid-induced dystrophic neurites and tau phosphorylation in Alzheimer's disease model mice.
    Acta Neuropathol. 2025;149:51.
    PubMed     Abstract available
    
    
    
49. BRAAK H, Mayer B, Feldengut S, Schon M, et al
    Sequence and trajectory of early Alzheimer's disease-related tau inclusions in the hippocampal formation of cases without amyloid-beta deposits.
    Acta Neuropathol. 2025;149:50.
    PubMed     Abstract available
    
    
    
50. FARRELL C, Buhidma Y, Mumford P, Heywood WE, et al
    Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease.
    Acta Neuropathol. 2025;149:49.
    PubMed     Abstract available
    
    
    
51. KAVANAGH T, Thierry M, Balcomb K, Ponce J, et al
    The interactome of tau phosphorylated at T217 in Alzheimer's disease human brain tissue.
    Acta Neuropathol. 2025;149:44.
    PubMed     Abstract available
    
    
    April 2025
52. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
    Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
    Acta Neuropathol. 2025;149:34.
    PubMed    
    
    
    
53. FELEKE R, Jogaudaite S, Velentza-Almpani E, Yeung-Yeung L, et al
    Seeding-competent early tau multimers are associated with cell type-specific transcriptional signatures.
    Acta Neuropathol. 2025;149:31.
    PubMed     Abstract available
    
    
    March 2025
54. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Ashton NJ, Pola I, et al
    Biofluid-based staging of Alzheimer's disease.
    Acta Neuropathol. 2025;149:27.
    PubMed     Abstract available
    
    
    
55. GHATAMANENI S, Hruska C, Shin I, Bruinsma T, et al
    High resolution autoradiography of [(18)F]MK-6240 and [(18)F]Flortaucipir shows similar neurofibrillary tangle binding patterns preferentially recognizing middling neurofibrillary tangle maturity.
    Acta Neuropathol. 2025;149:26.
    PubMed     Abstract available
    
    
    February 2025
56. EBNER BA, Erdahl SA, Lundgreen CS, Vassilaki M, et al
    Brain tissue metal concentrations and Alzheimer's disease neuropathology in total joint arthroplasty patients versus controls.
    Acta Neuropathol. 2025;149:18.
    PubMed     Abstract available
    
    
    
57. FIXEMER S, Miranda de la Maza M, Hammer GP, Jeannelle F, et al
    Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus.
    Acta Neuropathol. 2025;149:19.
    PubMed     Abstract available
    
    
    January 2025
58. MARTA-ARIZA M, Leitner DF, Kanshin E, Suazo J, et al
    Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease.
    Acta Neuropathol. 2025;149:9.
    PubMed     Abstract available
    
    
    
59. SAEZ-CALVERAS N, Vaquer-Alicea J, White CL 3rd, Tak Y, et al
    Essential tremor with tau pathology features seeds indistinguishable in conformation from Alzheimer's disease and primary age-related tauopathy.
    Acta Neuropathol. 2025;149:6.
    PubMed     Abstract available
    
    
    December 2024
60. MOONEN S, Koper MJ, Van Schoor E, Schaeverbeke JM, et al
    Correction: Pyroptosis in Alzheimer's disease: cell type?specific activation in microglia, astrocytes and neurons.
    Acta Neuropathol. 2024;149:3.
    PubMed    
    
    
    
61. KADAMANGUDI S, Marcatti M, Zhang WR, Fracassi A, et al
    Amyloid-beta oligomers increase the binding and internalization of tau oligomers in human synapses.
    Acta Neuropathol. 2024;149:2.
    PubMed     Abstract available
    
    
    
62. SCHREMPEL S, Kottwitz AK, Piechotta A, Gnoth K, et al
    Identification of isoAsp7-Abeta as a major Abeta variant in Alzheimer's disease, dementia with Lewy bodies and vascular dementia.
    Acta Neuropathol. 2024;148:78.
    PubMed     Abstract available
    
    
    November 2024
63. ROY N, Haq I, Ngo JC, Bennett DA, et al
    Elevated expression of the retrotransposon LINE-1 drives Alzheimer's disease-associated microglial dysfunction.
    Acta Neuropathol. 2024;148:75.
    PubMed     Abstract available
    
    
    
64. BALCOMB K, Johnston C, Kavanagh T, Leitner D, et al
    SMOC1 colocalizes with Alzheimer's disease neuropathology and delays Abeta aggregation.
    Acta Neuropathol. 2024;148:72.
    PubMed     Abstract available
    
    
    
65. PHILLIPS JM, Winfree RL, Seto M, Schneider JA, et al
    Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer's disease.
    Acta Neuropathol. 2024;148:69.
    PubMed     Abstract available
    
    
    
66. KATSUMATA Y, Wu X, Aung KZ, Fardo DW, et al
    Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer's pathologies.
    Acta Neuropathol. 2024;148:66.
    PubMed     Abstract available
    
    
    
67. GARLAND EF, Antony H, Kulagowska L, Scott T, et al
    The microglial translocator protein (TSPO) in Alzheimer's disease reflects a phagocytic phenotype.
    Acta Neuropathol. 2024;148:62.
    PubMed     Abstract available
    
    
    October 2024
68. VATTATHIL SM, Tan SSM, Kim PJ, Bennett DA, et al
    Effects of brain microRNAs in cognitive trajectory and Alzheimer's disease.
    Acta Neuropathol. 2024;148:59.
    PubMed     Abstract available
    
    
    
69. SHANAKI BAVARSAD M, Spina S, Oehler A, Allen IE, et al
    Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation.
    Acta Neuropathol. 2024;148:58.
    PubMed     Abstract available
    
    
    
70. WANG YR, Zeng XQ, Wang J, Fowler CJ, et al
    Autoantibodies to BACE1 promote Abeta accumulation and neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2024;148:57.
    PubMed     Abstract available
    
    
    
71. LAUREYSSEN C, Kucukali F, Van Dongen J, Gawor K, et al
    Hypothesis-based investigation of known AD risk variants reveals the genetic underpinnings of neuropathological lesions observed in Alzheimer's-type dementia.
    Acta Neuropathol. 2024;148:55.
    PubMed     Abstract available
    
    
    September 2024
72. GIONG HK, Hyeon SJ, Lee JG, Cho HJ, et al
    Tau accumulation is cleared by the induced expression of VCP via autophagy.
    Acta Neuropathol. 2024;148:46.
    PubMed     Abstract available
    
    
    
73. FREIBURGHAUS T, Pawlik D, Oliveira Hauer K, Ossenkoppele R, et al
    Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions.
    Acta Neuropathol. 2024;148:44.
    PubMed     Abstract available
    
    
    
74. DENNING AE, Ittyerah R, Levorse LM, Sadeghpour N, et al
    Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer's disease continuum.
    Acta Neuropathol. 2024;148:37.
    PubMed     Abstract available
    
    
    August 2024
75. SCHRODER S, Fuchs U, Gisa V, Pena T, et al
    PRDM16-DT is a novel lncRNA that regulates astrocyte function in Alzheimer's disease.
    Acta Neuropathol. 2024;148:32.
    PubMed     Abstract available
    
    
    
76. BOTELLA LUCENA P, Heneka MT
    Inflammatory aspects of Alzheimer's disease.
    Acta Neuropathol. 2024;148:31.
    PubMed     Abstract available
    
    
    
77. MA Y, Reyes-Dumeyer D, Piriz A, Recio P, et al
    Epigenetic and genetic risk of Alzheimer disease from autopsied brains in two ethnic groups.
    Acta Neuropathol. 2024;148:27.
    PubMed     Abstract available
    
    
    
78. HART DE RUYTER FJ, Evers MJAP, Morrema THJ, Dijkstra AA, et al
    Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Acta Neuropathol. 2024;148:24.
    PubMed     Abstract available
    
    
    
79. HOQ MR, Fernandez A, Vago FS, Hallinan GI, et al
    Cryo-EM structures of cotton wool plaques' amyloid beta and of tau filaments in dominantly inherited Alzheimer disease.
    Acta Neuropathol. 2024;148:20.
    PubMed     Abstract available
    
    
    
80. JURY-GARFE N, Redding-Ochoa J, You Y, Martinez P, et al
    Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer's disease.
    Acta Neuropathol. 2024;148:15.
    PubMed     Abstract available
    
    
    July 2024
81. LEITNER D, Kavanagh T, Kanshin E, Balcomb K, et al
    Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment.
    Acta Neuropathol. 2024;148:9.
    PubMed     Abstract available
    
    
    
82. KASRI A, Camporesi E, Gkanatsiou E, Boluda S, et al
    Amyloid-beta peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
    Acta Neuropathol. 2024;148:8.
    PubMed     Abstract available
    
    
    
83. SHI H, Mirzaei N, Koronyo Y, Davis MR, et al
    Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status.
    Acta Neuropathol. 2024;148:3.
    PubMed     Abstract available
    
    
    June 2024
84. QU W, Lam M, McInvale JJ, Mares JA, et al
    Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APP(V717I) mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator.
    Acta Neuropathol. 2024;147:107.
    PubMed     Abstract available
    
    
    
85. OLLEN-BITTLE N, Pejhan S, Pasternak SH, Keene CD, et al
    Co-registration of MALDI-MSI and histology demonstrates gangliosides co-localize with amyloid beta plaques in Alzheimer's disease.
    Acta Neuropathol. 2024;147:105.
    PubMed     Abstract available
    
    
    
86. WOODWORTH DC, Nguyen KM, Sordo L, Scambray KA, et al
    Comprehensive assessment of TDP-43 neuropathology data in the National Alzheimer's Coordinating Center database.
    Acta Neuropathol. 2024;147:103.
    PubMed     Abstract available
    
    
    
87. HOGLUND Z, Ruiz-Uribe N, Del Sastre E, Woost B, et al
    Brain vasculature accumulates tau and is spatially related to tau tangle pathology in Alzheimer's disease.
    Acta Neuropathol. 2024;147:101.
    PubMed     Abstract available
    
    
    
88. SARKANY B, David C, Hortobagyi T, Gombas P, et al
    Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus.
    Acta Neuropathol. 2024;147:98.
    PubMed     Abstract available
    
    
    
89. GAO F, Zhang M, Wang Q, Ni M, et al
    Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease.
    Acta Neuropathol. 2024;147:97.
    PubMed     Abstract available
    
    
    
90. BALUSU S, De Strooper B
    The necroptosis cell death pathway drives neurodegeneration in Alzheimer's disease.
    Acta Neuropathol. 2024;147:96.
    PubMed     Abstract available
    
    
    
91. ANDO K, Kucukali F, Doeraene E, Nagaraj S, et al
    Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression.
    Acta Neuropathol. 2024;147:94.
    PubMed     Abstract available
    
    
    May 2024
92. GRANHOLM AE, Englund E, Gilmore A, Head E, et al
    Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings.
    Acta Neuropathol. 2024;147:92.
    PubMed     Abstract available
    
    
    
93. THIERRY M, Ponce J, Marta-Ariza M, Askenazi M, et al
    The influence of APOE(epsilon4) on the pTau interactome in sporadic Alzheimer's disease.
    Acta Neuropathol. 2024;147:91.
    PubMed     Abstract available
    
    
    
94. ELLIS MJ, Lekka C, Holden KL, Tulmin H, et al
    Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry.
    Acta Neuropathol. 2024;147:87.
    PubMed     Abstract available
    
    
    
95. FANCY NN, Smith AM, Caramello A, Tsartsalis S, et al
    Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.
    Acta Neuropathol. 2024;147:78.
    PubMed     Abstract available
    
    
    April 2024
96. BHATTARAI P, Gunasekaran TI, Belloy ME, Reyes-Dumeyer D, et al
    Rare genetic variation in fibronectin 1 (FN1) protects against APOEepsilon4 in Alzheimer's disease.
    Acta Neuropathol. 2024;147:70.
    PubMed     Abstract available
    
    
    
97. THAL DR, Gawor K, Moonen S
    Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis.
    Acta Neuropathol. 2024;147:69.
    PubMed     Abstract available
    
    
    
98. JAISA-AAD M, Munoz-Castro C, Healey MA, Hyman BT, et al
    Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias.
    Acta Neuropathol. 2024;147:66.
    PubMed     Abstract available
    
    
    
99. WACHTER A, Woodbury ME, Lombardo S, Abdourahman A, et al
    Landscape of brain myeloid cell transcriptome along the spatiotemporal progression of Alzheimer's disease reveals distinct sequential responses to Abeta and tau.
    Acta Neuropathol. 2024;147:65.
    PubMed     Abstract available
    
    
    March 2024
100. BOUTER Y, Noguerola JSL, Tucholla P, Crespi GAN, et al
     Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
     Acta Neuropathol. 2024;147:59.
     PubMed    
     
     
     
101. MALDONADO-DIAZ C, Hiya S, Yokoda RT, Farrell K, et al
     Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
     Acta Neuropathol. 2024;147:58.
     PubMed     Abstract available
     
     
     
102. XU H, Qiu Q, Hu P, Hoxha K, et al
     MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons.
     Acta Neuropathol. 2024;147:55.
     PubMed     Abstract available
     
     
     
103. WALTON RL, Koga S, Beasley AI, White LJ, et al
     Role of GBA variants in Lewy body disease neuropathology.
     Acta Neuropathol. 2024;147:54.
     PubMed     Abstract available
     
     
     February 2024
104. ALEXANDER A, Alvarez VE, Huber BR, Alosco ML, et al
     Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE.
     Acta Neuropathol. 2024;147:45.
     PubMed     Abstract available
     
     
     
105. MALIK N, Miah MU, Galgani A, McAleese K, et al
     Regional AT-8 reactive tau species correlate with intracellular Abeta levels in cases of low AD neuropathologic change.
     Acta Neuropathol. 2024;147:40.
     PubMed     Abstract available
     
     
     
106. WU YC, Bogale TA, Koistinaho J, Pizzi M, et al
     The contribution of beta-amyloid, Tau and alpha-synuclein to blood-brain barrier damage in neurodegenerative disorders.
     Acta Neuropathol. 2024;147:39.
     PubMed     Abstract available
     
     
     
107. COLOM-CADENA M, Toombs J, Simzer E, Holt K, et al
     Transmembrane protein 97 is a potential synaptic amyloid beta receptor in human Alzheimer's disease.
     Acta Neuropathol. 2024;147:32.
     PubMed     Abstract available
     
     
     
108. OERTEL FC, Casillas D, Cobigo Y, Condor Montes S, et al
     Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies".
     Acta Neuropathol. 2024;147:30.
     PubMed    
     
     
     
109. CHUNG M, Carter EK, Veire AM, Dammer EB, et al
     Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
     Acta Neuropathol. 2024;147:29.
     PubMed     Abstract available
     
     
     January 2024
110. LEITNER D, Pires G, Kavanagh T, Kanshin E, et al
     Similar brain proteomic signatures in Alzheimer's disease and epilepsy.
     Acta Neuropathol. 2024;147:27.
     PubMed     Abstract available
     
     
     
111. AGUERO C, Dhaynaut M, Amaral AC, Moon SH, et al
     Head-to-head comparison of [(18)F]-Flortaucipir, [(18)F]-MK-6240 and [(18)F]-PI-2620 postmortem binding across the spectrum of neurodegenerative diseases.
     Acta Neuropathol. 2024;147:25.
     PubMed     Abstract available
     
     
     
112. FAZELI E, Child DD, Bucks SA, Stovarsky M, et al
     A familial missense variant in the Alzheimer's disease gene SORL1 impairs its maturation and endosomal sorting.
     Acta Neuropathol. 2024;147:20.
     PubMed     Abstract available
     
     
     
113. VAN DER GAAG BL, Deshayes NAC, Breve JJP, Bol JGJM, et al
     Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
     Acta Neuropathol. 2024;147:14.
     PubMed     Abstract available
     
     
     
114. LANTERO-RODRIGUEZ J, Montoliu-Gaya L, Benedet AL, Vrillon A, et al
     CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease.
     Acta Neuropathol. 2024;147:12.
     PubMed     Abstract available
     
     
     
115. AGRA ALMEIDA QUADROS AR, Li Z, Wang X, Ndayambaje IS, et al
     Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
     Acta Neuropathol. 2024;147:9.
     PubMed     Abstract available
     
     
     
116. TAYLOR LW, Simzer EM, Pimblett C, Lacey-Solymar OTT, et al
     p-tau Ser356 is associated with Alzheimer's disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003.
     Acta Neuropathol. 2024;147:7.
     PubMed     Abstract available
     
     
     December 2023
117. MONTOLIU-GAYA L, Alosco ML, Yhang E, Tripodis Y, et al
     Optimal blood tau species for the detection of Alzheimer's disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study.
     Acta Neuropathol. 2023;147:5.
     PubMed     Abstract available
     
     
     
118. CHANG K, Ling JP, Redding-Ochoa J, An Y, et al
     Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
     Acta Neuropathol. 2023;147:4.
     PubMed     Abstract available
     
     
     November 2023
119. VANDEVREDE L, La Joie R, Horiki S, Mundada NS, et al
     Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
     Acta Neuropathol. 2023;146:777-781.
     PubMed    
     
     
     September 2023
120. SORDO L, Qian T, Bukhari SA, Nguyen KM, et al
     Characterization of hippocampal sclerosis of aging and its association with other neuropathologic changes and cognitive deficits in the oldest-old.
     Acta Neuropathol. 2023;146:415-432.
     PubMed     Abstract available
     
     
     August 2023
121. NGUYEN AT, Wang K, Hu G, Wang X, et al
     Correction: APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer's disease.
     Acta Neuropathol. 2023 Aug 17. doi: 10.1007/s00401-023-02620.
     PubMed    
     
     
     
122. JUDD JM, Jasbi P, Winslow W, Serrano GE, et al
     Inflammation and the pathological progression of Alzheimer's disease are associated with low circulating choline levels.
     Acta Neuropathol. 2023 Aug 7. doi: 10.1007/s00401-023-02616.
     PubMed     Abstract available
     
     
     
123. MATE DE GERANDO A, Welikovitch LA, Khasnavis A, Commins C, et al
     Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau.
     Acta Neuropathol. 2023;146:191-210.
     PubMed     Abstract available
     
     
     July 2023
124. NEUMANN M, Perneel J, Cheung S, Van den Broeck M, et al
     Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology.
     Acta Neuropathol. 2023;146:163-166.
     PubMed    
     
     
     
125. YU L, Boyle PA, Janelidze S, Petyuk VA, et al
     Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults.
     Acta Neuropathol. 2023;146:1-11.
     PubMed     Abstract available
     
     
     June 2023
126. BERMUDEZ C, Graff-Radford J, Syrjanen JA, Stricker NH, et al
     Plasma biomarkers for prediction of Alzheimer's disease neuropathologic change.
     Acta Neuropathol. 2023 Jun 3. doi: 10.1007/s00401-023-02594.
     PubMed     Abstract available
     
     
     
127. FILIPELLO F, You SF, Mirfakhar FS, Mahali S, et al
     Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
     Acta Neuropathol. 2023;145:749-772.
     PubMed     Abstract available
     
     
     May 2023
128. MANCA M, Standke HG, Browne DF, Huntley ML, et al
     Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
     Acta Neuropathol. 2023 May 8. doi: 10.1007/s00401-023-02574.
     PubMed     Abstract available
     
     
     
129. HOQ MR, Bharath SR, Hallinan GI, Fernandez A, et al
     Cross-beta helical filaments of Tau and TMEM106B in gray and white matter of multiple system tauopathy with presenile dementia.
     Acta Neuropathol. 2023;145:707-710.
     PubMed    
     
     
     March 2023
130. CHENG Y, He CY, Tian DY, Chen SH, et al
     Physiological beta-amyloid clearance by the liver and its therapeutic potential for Alzheimer's disease.
     Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02559.
     PubMed     Abstract available
     
     
     
131. WINFREE RL, Seto M, Dumitrescu L, Menon V, et al
     TREM2 gene expression associations with Alzheimer's disease neuropathology are region-specific: implications for cortical versus subcortical microglia.
     Acta Neuropathol. 2023 Mar 25. doi: 10.1007/s00401-023-02564.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum